Tuesday, 14 January 2020

New Opportunities In Global Coronary Angiography Devices Market Size, Share, Growth and Demand

Market Highlights
The coronary angiography procedure is used to diagnose coronary heart disease and coronary microvascular disease after the sudden cardiac arrest, chest pain, and strokes. This procedure is carried out before surgical procedures such as coronary angioplasty.

The global coronary angiography market is driven by growing prevalence of cardiovascular diseases, increasing geriatric population, and benefits of the procedure for early diagnosis. According to the American Heart Association, fact sheet 2016, an estimated 85.6 million American adults had one or more types of cardiovascular diseases. In addition to these, 43.7 million were estimated to be 60 or above years of age. Moreover, technological advancements in angiography devices, raising awareness for diagnosis of heart diseases, and growing preference for minimally invasive procedures with improved medical imaging is likely to contribute to the market growth. Furthermore, increasing R&D activities and continuous products launch by leading market players enhances the market growth during the forecast period. For instance, in 2016, Siemens Healthineers launched innovative robot-supported Artis phenol angiography system.

However, limitations in reimbursement policies and changing government regulations restrain the market growth. Moreover, factors such as high cost of angiography devices and lack of skilled medical professional are likely to hamper the market growth during the assessment period.

Coronary Angiography Devices Market Regional Analysis
The Americas dominates the global coronary angiography devices market. Factors such as the rising prevalence of coronary heart disease and presence of a well-developed healthcare sector within the region drive the market growth during the forecast period. Europe stands second in the global coronary angiography devices market. This can be attributed to the increasing availability of funds for research, a huge patient population with cardiac diseases and a well-developed healthcare sector within Europe. Moreover, growing geriatric and obese population boosts the market growth. Followed by Europe, Asia Pacific is estimated to be the fastest growing region. Presence of developing economies, increasing prevalence of cardiovascular diseases, and rising healthcare expenditure drives the market growth within the region. On the other hand, the Middle East & Africa has the least share in the global market due to the low per capita healthcare expenditure and stringent government policies, especially within the Africa region. It is estimated that the Middle East holds a majority of the market within the Middle East and Africa region.

Segmentation
The global coronary angiography devices market is segmented on the basis of the product, devices, procedures, technology, indication, application, and end-user. On the basis of the product, the market is classified into angiography systems, angiography catheters, angiography contrast media, Vascular Closure Devices (VCDs), angiography balloons, angiography Guidewires, and angiography accessories. The global coronary angiography devices market on the basis of devices is segmented into Magnetic Resonance Angiography (MRA), Computed Tomography Angiography (CTA), conventional angiography, Digital Subtraction Angiography (DSA), Catheter angiography, coronary angiography, and others. On the basis of the procedure, the market is segmented as coronary angiography, endovascular angiography, peripheral vascular angiography, and other angiography procedures. On the basis of technology, the market is segmented into X-ray angiography, CT angiography, MR angiography, and other angiography technologies. On the basis of indication, the global coronary angiography devices market is segmented into coronary artery disease, valvular heart disease, congenital heart disease, congestive heart failure, and other indications. The global coronary angiography devices market on the basis of application is segmented into diagnostics and therapeutics. On the basis of end-user, the market is segmented into hospitals and clinics, diagnostic and imaging centers, and research institutes.

Global Coronary Angiography Devices Market Key Players
Some the prominent players in the global coronary angiography devices market Terumo, Boston Scientific Corporation, Canon Medical Systems, Cordis ( A Cardinal Health Company), B. Braun Melsungen AG, Angiodynamics, Abbott Vascular (Abbott Laboratories), Toshiba Medical Systems Corporation, Royal Philips Electronics, GE Healthcare, Medtronic, Inc., Shimadzu Corporation, and Siemens Healthcare.


About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
 Contact:
Market Research Future
+1 646 845 9312

Acupuncture Market to Witness Exponential Rise in Revenue Share During the Forecast Period (2019-2028) Current Trends and Future Demand of Acupuncture Market Outlook To 2023

Acupuncture Market Research Report.
Acupuncture is an alternative medicine approach which uses needles that are inserted into the skin at acupuncture points to treat several diseases. Acupuncture has notably emerged from China as a component of their health care system. The overall working of acupuncture is based on the foundation that there are patterns of energy flow, Qi, through the body which are important for health, and acupuncture corrects the imbalances of flow at identifiable points close to the skin. The market is expected to expand with a CAGR of 14.50 percent while earning revenues worth USD 55323.8 million in the duration of the forecast period from 2018 to 2023.
The market growth is fuelled by factors such as the growing incidence of gynecological disorders such as menstrual issues, PMS, PCOS, pregnancy complaints, menopause, infertility, and chronic pain disorders which are encouraging the development of the acupuncture market globally. Additionally, the rising occurrence of chronic diseases such as fibromyalgia and migraines which lead to health complications such as insomnia, body pain, and psychological illness will boost the progress of the acupuncture market globally. The escalating demand for non-invasive and painless acupuncture has led to an increase in the level of advancements in acupuncture therapy. The advent of technically advanced acupuncture treatments such as the usage of laser devices and electro acupuncture is projected to improve the development of the acupuncture market internationally for the duration of the forecast period. Moreover, many notable competitors are getting involved in the development and manufacturing of laser and electro acupuncture devices.
Increasing health complications in the elderly population such as sleep disturbances, body pain, and emotional disorders have also powered the development of the market. The mounting geriatric population worldwide is anticipated to influence the acupuncture market in the forecast period. The intensifying demand for alternative and complementary medicine like acupuncture has enhanced the funding scenario for the market which can be a vast opportunity for the expansion of the market through the forecast period. The funding from market contenders and new entrants in the market is likely to add to the market’s growth in the forecast period.
Segmental Analysis
The acupuncture market is segmented on the basis of application, end user, product & services. The segmentation of the market on the basis of product & services comprises of services and products. The service segment is further segmented into Japanese acupuncture, traditional Chinese medicine, auricular, Korean hand acupuncture, and scalp acupuncture, moxibustion, non-insertion acupuncture, cupping, and others. The product segment is additionally segmented into suction cups, needles, rod lasers, laser needle, and laser pens, electro-acupuncture device, and others. The needles are additionally sub segmented into modern needles and traditional needles. The service segment controls the acupuncture market by product & services due to the growing preference given to traditional acupuncture therapies. By application, the market is segmented into gynecological disorders, pain syndrome illnesses, psychological illnesses, and others. Pain syndrome illnesses controls the major market share of 33.5 percent over the forecast period, and it is also projected to develop at a CAGR of 14.04 percent through the forecast period. The end user segment of the market is segmented into hospitals & specialty clinics, wellness center, and research & academic institutes. Wellness Centre will possibly control the global acupuncture market due to a huge number of wellness center involved in acupuncture therapies and the rising preference for acupuncture as alternative medicine.

Detailed Regional Analysis 
The regional analysis of the market observes that the European region is expected to control the prime market share in the acupuncture market globally and is projected to develop at a CAGR of 13.53 percent during the forecast period. The market development is accredited to the intensifying occurrences of chronic diseases and growing preference for acupuncture therapies amongst the European population. Furthermore, the existence of major market contenders significantly adds to the market growth in the region. Additionally, the escalating insurance coverage in nations like France, Austria, Spain, and others, by other private companies will offer a promising backdrop for the market growth in the European region.
The Asia Pacific region is likely to be the most swiftly increasing region in the acupuncture market globally and is anticipated to develop at a CAGR of 15.02 percent for the duration of the assessment period. The growth of the Asia Pacific acupuncture market is credited to the existence of nations such as Korea, China, and Japan which has a high adoption rate for acupuncture therapies. Additionally, the growing number of companies manufacturing the acupuncture products and the rising prevalence of chronic diseases is powering the market growth in this region.
Competitive Analysis
Several competitors are functioning in the acupuncture market globally. Many organizations, particularly in the European and Asia Pacific regions, have their manufacturing units, while some organizations are also involved in import from other regions. As the Asia Pacific is one of the most rapidly rising markets, firms are grasping the chances that are available and are keenly expanding their units in this region. However, the acupuncture market is presently controlled by a few players. The major competitors outlined in the report comprises of Zepter International, schwa-medico GmbH, MKW Lasersystem GmbH, Wuxi Jiajian Medical Instruments Co., Ltd, Cymedics GmbH & Co. KG, 3B Scientific GmbH, Kanson, SEIRIN Corporation, Asia med GmbH, Qingdao Great Fortune Co. Ltd, and AcuMedic Ltd.
 About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312

Veterinary Pain Management Market- Global Trends and Forecast to 2023


Market Highlights:
Veterinary Pain Management Market is growing rapidly and pervasively mainly due to the spreading awareness towards animal care. People are generally compassionate towards their pets, and they are increasingly becoming aware of animal physiology and psychology and the pain they go through during sickness, injuries, recoveries and after effects of the diseases. Besides, factors such as the increasing number of pet owners and the strengthening bond between owners and their animal companions escalate the market on the global heights.



Acknowledging the rapid expansions, the market perceives currently, Market Research Future (MRFR) in its recently published study report asserts that the global veterinary pain management market will reach significant growth heights by 2023 registering 8.2% CAGR during the review period (2018 – 2023).
Additional factors substantiating the market growth include the rising per capita income that is leading to increasing the pet adoptions and the trend of nuclear families. Increased awareness concerning animal cruelty is influencing people’s ideologies and knowledge about animals.
Moreover, developments in animal health medicines and vaccines, along with the increased medical treatments are fostering the market growth of veterinary pain management market. Increased R&D expenditure to bring innovations in the products, and development of better and effective veterinary pharmaceuticals and vaccines, etc. are contributing to the market growth.
Improving economic conditions worldwide foster market growth, enabling access to the quality of life, increasing consumers’ buying power, and availing cost-effective veterinary healthcare.
On the other hand, factors such as the lack of awareness and knowledge pertaining to the animal well-being and the rising cost of pet care, etc. are expected to impede the market growth. Also, unavailability of skilled doctors is a major restraint the market is confronting with.  Nevertheless, technological advancement, increasing number of ambulatory services coupled with the government and public organizations initiatives like PETA, working towards animal rights and liberation are expected to support market growth.

Veterinary Pain Management Market   - Segmentations
MRFR has segmented the analysis into seven key dynamics for better understanding: -

By Drug Type: Nonsteroidal Anti-Inflammatory Drugs, Opioids, Local Anesthetics, Α2-Adrenergic Agonists, Muscle Relaxants, Sedatives, and Corticosteroids among others.
By Devices: Laser Therapy Devices and Electromagnetic Therapy Devices among others.
By Route of Administration: Oral, Parenteral, and Topical among others. 
By Animal Type: Companion Animals, Livestock, Research Animals, Aquatic Animals, Zoo Animals, and Exotic Animals among others.
By Application: Joint Pain, Postoperative Pain, and Cancer among others.
By End-user: Veterinary Hospitals & Clinics, Research Institutes & Universities, and Laboratories among others.                                                                                                                  
By Regions:  Europe, North America, APAC and the Rest-of-the-World.

Veterinary Pain Management Market   - Geographical Analysis
The North American region accounts for the leading market for veterinary pain management majorly due to the availability of a range of animal care products, emphasis on animal health, and stringent government regulations.  Also, technological innovations in the field of veterinary surgical instruments are acting as a tailwind pushing up the market growth in the region. 

Additional factors such as growing insurance coverage schemes are expected to push the growth of the veterinary pain management market in the region. Moreover, the increasing number of pets and a large patients’ pool, contribute to the growth of the regional market, demanding various treatment procedures and surgeries.
Countries such as Canada and the US are focusing on exporting surgical equipment and surgical suturing material across the world, which, in turn, is increasing the size of the market in this region. Besides, the growing number of veterinary hospitals fuel market growth.
The Veterinary Pain Management Market in the European region stands the second position in terms of the market size, owing to the increasing pet ownership fuelled by the tax benefits granted by the government.  Increase in animal diseases has led to an increasing number of surgeries and veterinary healthcare organizations. European countries like Germany, France, and the U.K, backed by the significant expenditures in the field of manufacturing of veterinary medical and surgical devices, majorly contributes to the growth of the regional market.
The Asia Pacific region is emerging as a promising market for companion veterinary pain management. China among other APAC dominates the regional market whereas, India accounts for the fastest growing market, followed by Australia and Japan.  Factors such as the presence of a large patient’s pool, increasing awareness towards animal health, and the improving economy are few of the driving forces pushing up the market in the region.
Veterinary Pain Management Market   - Competitive Landscape
The fiercely competitive veterinary pain management market appears to be fragmented due to many players forming a competitive landscape. Mergers & acquisitions, innovations, and Brand reinforcement remain the popular trends for the market players. Acquisitions of local manufactures by multinational companies are changing the market structure, increasing the profit of the company by reducing the competition significantly.

Key Players:
Some of the players leading the market include Zoetis, Boehringer Ingelheim, Chanelle, Ceva Santé Animale, Dechra Pharmaceuticals, Norbrook Laboratories, Merck Animal Health, Elanco, Assisi Animal Health, Bayer, and Vetoquinol.

Industry/ Innovation/ Related News:

November 08, 2018 – Vetoquinol USA, a world-class developer of veterinarian-approved formulas for large animal healthcare products, announced the launch of its rebranded product line - EQUISTRO®. The rebranding includes new packaging for products and others. All EQUISTRO products are now available in veterinary clinics and in retail stores that sell feed, farm supplies, horse tack, and equine products. The rebranding strategy helps to expand the products available for performance horses through Vetoquinol.



About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
 Contact:
Market Research Future
+1 646 845 9312

Barotrauma Market Development History, Current Analysis and Estimated Forecast to 2023

Barotrauma Market Highlights

Owing to the increasing cases of ear barotrauma, technological advancements, increasing healthcare expenditure, unmet medical needs, patent expiration of blockbuster drugs, enhancing regulatory framework, increasing government assistance, and rising funding and reimbursement, the barotrauma market has evolved significantly.
However, huge capital investments with low-profit margins, strict FDA regulations, and poor healthcare system in the low and middle-income countries are likely to hamper the growth of the barotrauma market over the forecast period.
It is estimated that the Barotrauma Market is expected to have a CAGR of 6.5% during the forecast period of 2017–2023.
Regional Analysis
The Americas dominates the barotrauma market owing to the increasing prevalence of ear barotrauma and high healthcare expenditure.
Europe holds the second position in the barotrauma market. The financial support provided by the government towards R&D and technological advancements are expected to drive the European barotrauma market. The increasing healthcare expenditure is also boosting the European barotrauma market.


According to the data suggested by Eurostat, it is observed that among the EU Member States, the highest value of healthcare expenditure was recorded in Germany in 2014, i.e., EUR 321 billion which is further followed by France with EUR 237 billion and United Kingdom with EUR 223 billion. In 2016, the R&D expenditure in the pharmaceutical industry was EUR 35000 million, suggested by the European Federation of Pharmaceutical Industries and Association.
Asia Pacific is the fastest growing barotrauma market owing to a huge patient pool and development in the pharmaceutical sector. Healthcare expenditure is found to be boosting in various regions of Asia Pacific. As per the data suggested by the Australian Institute of Health and Welfare during the year 2015–2016, the total health expenditure was nearly USD 170.4 billion, i.e., 3.6% higher than the expenditure of 2014–2015.
The Middle East and Africa holds the lowest share of the global market due to slow development, lack of technical knowledge, and poor medical facilities.
Segmentation
The global barotrauma market is segmented by type, diagnosis, treatment, and end-user.
On the basis of type, the barotrauma market is classified as ear barotrauma, sinus barotrauma, and pulmonary (lung) barotrauma.
On the basis of diagnosis, the barotrauma market is classified as otoscopy, X-ray, Computed Tomography (CT) scan, pulmonary function test, lung perfusion scan, Magnetic Resonance Imaging (MRI), pulse oximetry, and others.
On the basis of treatment, the barotrauma market is classified as pressure relief, medications, surgery, oxygen treatment, recompression therapy, and others. The medications segment is further classified as decongestant nasal sprays, oral decongestants, oral antihistamines, painkillers, antibiotics, and others. The surgery segment is further classified as Functional Endoscopic Sinus Surgery (FESS), tympanostomy, Single Laparoscopic Incision Transabdominal (SLIT), and others.
On the basis of end-user, the barotrauma market is segmented into hospitals and clinics, trauma centers, pharmaceutical companies, medical device companies, academic and research institutes, and others.
Key Players
Some of the key players in the global barotrauma market are 3M, Accurate Surgical & Scientific Instruments Corporation, AptarGroup, AstraZeneca plc., Atos Medical, CellScope, Entellus Medical Inc., GlaxoSmithKline plc, HEINE, Inventis, Johnson & Johnson Services, Inc., Merck & Co., Inc., Novartis AG, Olympus Corporation, Pfizer, Inc., Cipla Ltd., Mylan N.V., Preceptis Medical, Rudolf Riester GmbH, Shanghai Yuejin, SinuSys Corporation, Teva Pharmaceutical Industries Ltd., Ranbaxy Laboratories Ltd., Sklar Surgical Instruments, Smith & Nephew Plc, Valeant pharmaceuticals International Inc., Hill-Rom, and others.
Table Of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Treatment Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Barotrauma Market, By Type
6.1 Introduction
6.2 Ear Barotrauma
6.2.1 Market Estimates & Forecast, 2017–2023
6.3 Sinus Barotrauma
6.3.1 Market Estimates & Forecast, 2017–2023
6.4 Pulmonary (Lung) Barotrauma
6.4.1 Market Estimates & Forecast, 2017–2023
Chapter 7. Global Barotrauma Market, By Diagnosis
7.1 Introduction
7.2 Otoscopy
7.2.1 Market Estimates & Forecast, 2017–2023
7.3 X-Ray
7.3.1 Market Estimates & Forecast, 2017–2023
7.4 Computed Tomography (CT) Scan
7.4.1 Market Estimates & Forecast, 2017–2023
7.5 Pulmonary Function Test
7.5.1 Market Estimates & Forecast, 2017–2023
7.6 Lung Perfusion Scan
7.6.1 Market Estimates & Forecast, 2017–2023
7.7 Computed Tomography (CT) Scan
7.7.1 Market Estimates & Forecast, 2017–2023
7.8 Pulmonary Function Test
7.8.1 Market Estimates & Forecast, 2017–2023
7.9 Lung Perfusion Scan
7.9.1 Market Estimates & Forecast, 2017–2023
Chapter 8. Global Barotrauma Market, By Treatment
8.1 Introduction
8.2 Pressure Relief
8.2.1 Market Estimates & Forecast, 2017–2023
8.3 Medications
8.3.1 Market Estimates & Forecast, 2017–2023
8.4 Surgery
8.4.1 Market Estimates & Forecast, 2017–2023
8.5 Oxygen Treatment
8.5.1 Market Estimates & Forecast, 2017–2023
8.6 Recompression Therapy
8.6.1 Market Estimates & Forecast, 2017–2023
8.7 Others
8.7.1 Market Estimates & Forecast, 2017–2023
Chapter 9. Global Barotrauma Market, By End-User
9.1 Introduction
9.2 Hospitals & Clinics
9.2.1 Market Estimates & Forecast, 2017–2023
9.3 Trauma Centers
9.3.1 Market Estimates & Forecast, 2017–2023
9.4 Pharmaceutical Companies
9.4.1 Market Estimates & Forecast, 2017–2023
9.5 Medical Device Companies
9.5.1 Market Estimates & Forecast, 2017–2023
9.6 Academic And Research Institutes
9.6.1 Market Estimates & Forecast, 2017–2023
9.7 Others
9.7.1 Market Estimates & Forecast, 2017–2023 


About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
 Contact:
Market Research Future
+1 646 845 9312

Discography Market is set to grow by 8.20% CAGR by 2023


Market Highlights
Growing geriatric population resulting in the increasing prevalence of degenerative disc disease, increasing per capita healthcare expenditure and rising investments in research and development processes is estimated to drive the market during the forecast period. However, factors such as high procedural cost, complications in the operations, lack of awareness and low per capita healthcare expenditure in the developing countries are restraining the market growth.
The global discography market is expected to grow at an approximate CAGR of 8.20% during the forecast period.
Segmentation
The global Discography Market is segmented on the basis of type, component, application, indication, and end user. On the basis of the type, the market is segmented into lumbar discography, cervical discography, thoracic discography, and others. On the basis of the component, the market is categorized into contrast agent, imaging and others. The contrast agent segment is sub-segmented into iodine, gadolinium, and others. The imaging segment is sub-segmented into X-ray, computed tomography (CT), magnetic resonance imaging (MRI), and others. On the basis of the application, the market is segmented into herniated discs, scoliosis, burst fracture, and others. On the basis of the indication, the market is segmented into spinal decompression, lumbar surgery, laminectomy, and others. On the basis of end user, the market is segmented into hospitals, retail pharmacies, academic institutes, others.
Regional Analysis
The Americas dominates the global discography market. Factors such as the presence of a well-developed healthcare sector, increasing prevalence of lower back pain, and rising healthcare expenditure provides the favorable backgrounds for the market growth within the region. Followed by Europe is the second large market for discography. Availability of funds for research, well developed healthcare infrastructure, huge patient population and government support for research & development are the major drivers for market growth in Europe. Asia Pacific is the fastest growing region for the market due to the presence of developing economies like India & China and favorable government policies. The Middle East & Africa has the least share in the global discography market due to presence of poor economies and stringent government policies within the region. Majority of the market of the Middle & Africa region is held by the Middle East due to a well-developed healthcare sector and huge healthcare expenditure by the presence of the economies like Saudi Arabia, Kuwait, and Qatar within the region.
Key Players
The key players for the global discography market are Stryker (U.S.), Johnson & Johnson Services, Inc. (U.S.), Merit Medical Systems, Inc. (U.S.), Medtronic (U.S.), GFS Chemicals, Inc. (U.S.), Avalon Advanced Materials (Canada), GE Healthcare (U.S.), Koninklijke Philips N.V. (the Netherlands), Canon Inc.  (Japan), Carestream Health. (U.S.), and others.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312

Monday, 13 January 2020

Europe Respiratory Therapeutic Devices Market Analysis and Industry Outlook to 2020


Europe Respiratory Therapeutic Devices Market – Overview:
Respiratory Therapeutic/ care devices are used for diagnosis, monitoring, and treatment of respiratory diseases such as COPD (chronic obstructive pulmonary disease), Chronic Bronchitis, Tuberculosis, Emphysema Asthma, and Pneumonia. These devices provide advanced care to patients suffering from severe and chronic respiratory diseases. Increasing prevalence of respiratory disorders & diseases in the region predominantly drives the market growth of Respiratory Therapeutic Devices in Europe.
Acknowledging the exponential growth the market perceives currently and gauging the potential the market holds to grow in the future; Market Research Future (MRFR), in its recently published market forecast asserts that the Europe Respiratory Therapeutic Devices Market will grow exponentially by 2020, registering a striking CAGR throughout the forecast period (2017 – 2020).

Major driving factors for the Europe respiratory caredevices market are the rise in the number of chronic pulmonary obstructive diseased patients, and the continuous surge in numbers due to changing lifestyle and environment such as increasing pollution level and smokers. Furthermore, rising geriatric population, the launching of the new product coupled with the robust pipeline of the product provide impetus to the market growth.
On the other hand, some of the harmful effects of respiratory devices and the low awareness in some of the developing regions are the factors affecting the market growth. Also, the excise tax on devices is expected to impact the market negatively in some countries.  
Europe Respiratory Therapeutic Devices Market – Segments
For the convenience of the report and enhanced understanding; MRFR has segmented the market into five key dynamics
By Products    : PAP Devices (CPAP Devices, APAP Devices, and BPAP Devices), Masks (Nasal Masks, Nasal Pillow Masks Full-Face Masks, and Oral Masks), Ventilators (Adult and Infant Ventilators), Nebulizers, Humidifiers (Heated and Passover Humidifiers), Oxygen Concentrators (Fixed and Portable Oxygen Concentrators), Inhalers (Dry Powder Inhalers and Metered Dose Inhalers), Resuscitators (Reusable and Disposable Resuscitators), Nitric Oxide Delivery Units, Oxygen Hoods, Others.
By Technology                   : Electrostatic Filtration, HEPA Filtration, Hollow Fiber Filtration, and Microsphere Separation among others.
By Applications : Asthma, Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis, and others.
By Modes of Care: Hospital Care & Home Care among others
By Regions           : Europe - Germany, France, U.K., Italy, Spain, and Rest of Europe
Segment - Hospital Care by Modes of Care dominates the market, owing to the financial capabilities of hospitals to purchase high cost devices. 
Europe Respiratory Therapeutic Devices Market – Competitive Analysis
The Europe Respiratory Therapeutic Devices market is fiercely competitive with the presence of several large and small players operating in the market. These market players acquire promising companies to expand in the fast-growing markets, focusing on improving their market performance. The market structure is dynamic due to the acquisition of local manufactures by the multinational companies. Strategies like product innovations and technologies are creating strong investment opportunities for the market players.
Industry, Innovation & Related News
April 18, 2018 –INSYS Therapeutics, Inc. (US), a leading global players in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology announced its partnership with Senzer Ltd. (UK) to take the clinical research of dronabinol inhalation to the next level using a novel and patented breath-actuated device—licensed from Senzer and accepted by the FDA, U.S. under an IND (investigational new drug) filing, in the second half of 2018.
April 19, 2018 – ICON plc. (Ireland), a leading global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, announced that it has reached a preliminary agreement with Intel to use the Intel Pharma Analytics Platform (AI-enabled remote monitoring) in clinical trials.
March 29, 2018 – Koninklijke Philips N.V. (The Netherlands) a leading global technology company focused in the area of healthcare, announced signing of a 15-Year Strategic Partnership Agreement with ZorgSaam (The Netherlands), a company offering hospital care, ambulance care, home care and elderly care to provide a wide range of integrated solutions for the diagnosis and treatment of patients.

Europe Respiratory Therapeutic Devices Market – Country-wise Analysis
Germany among the other European countries accounts for the leading market for Respiratory Therapeutic Devices, accounting for the largest revenue pocket, followed by the UK & France, respectively. The German market backed by the high expenditure on healthcare is the largest contributor to the Europe market growth. Moreover, increasing prevalence of respirational diseases & disorders coupled with the rising demand for treatment measures provides impetus to the market growth.
The UK stands the second-largest market in the Europe Respiratory Therapeutic Devices market. The strong market growth in the country drives the regional market growth, large scale, owing to the high per capita income and robust healthcare penetration in the country. Attributing to the increasing investment in healthcare and rising number of patients with respirational disorders & diseases, the UK market is projected to register a phenomenal CAGR during the forecast period.
France market for Respiratory Therapeutic Devices is expected to perceive an exponential growth, owing to the large patient pool and the burgeoning medical treatment market.      


About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312


EMEA Surgical Equipment Market - Industry Forecast to 2023


Market Highlights

A surgical equipment is a designed tool or device to carry out various surgical procedures so as to modifying biological tissues and to provide access for viewing them. The surgical equipment can be designed specifically for a particular surgery or it can be used as general purpose equipment. Increasing global burden of the diseases like Parkinson’s disease, heart disease, cancer, and others followed by growing geriatric population and rising healthcare expenditures facilitates the market growth during the forecast period. In 2017, according to the World Health Organization, cancer was the second leading global cause of deaths, and was responsible for about 8.8 million deaths in 2015. Moreover, it was established that ~70% of the deaths due to cancer occur in low- and middle-income countries. However, high cost of the devices, shortage of skilled labor and strict regulatory policies are the major restraints for the market growth.

Segmentation

The EMEA surgical equipment market is segmented on the basis of product type, application, and end users.

On the basis of product type, the market is segmented into surgical sutures and staples, handheld surgical equipment, electrosurgical devices, electrosurgical devices, and others. The handheld surgical equipment segment is sub-segmented into forceps and spatulas, retractors, dilators, graspers, auxiliary instruments, cutter instruments, electrosurgical devices, and others. The auxiliary instrument sub-segment, by handheld surgical equipment segment, is further segmented into clamps, cannulas, closure devices, and others. The cutter instruments sub-segment, by handheld surgical equipment segment, is further segmented into trocars, lancets, scissors, and others. The electrosurgical devices segment is sub segmented into electro surgical generators, bipolar instruments, and monopolar instruments. The bipolar instruments sub-segment, by electrosurgical devices segment, is sub segmented into vessel sealing, forceps, and others. The monopolar instruments sub-segment, by electrosurgical devices segment, is further segmented into pencils, electrodes, and others. The bipolar instruments sub-segment, by electrosurgical devices segment, is sub segmented into vessel sealing, forceps, and others. The monopolar instruments sub-segment, by electrosurgical devices segment, is further segmented into pencils, electrodes, and others.

On the basis of application, the market is segmented into neurosurgery, obstetrics and gynecology, orthopedic surgery, cardiovascular surgery, and others.

On the basis of end users, the market is segmented into hospitals & clinics, research organization, academic institutes, and others.

Regional Analysis

Europe holds the largest share of EMEA surgical equipment market. Availability of funds for research, huge patient population and government support for research & development drives the European market. Moreover, presence of the developed economies like the Germany, and U.K. within the region fuels the market growth during the forecast period. According to the Macmillan Cancer Support in 2014, 357 million people in the U.K are diagnosed with cancer every year. Moreover, by 2020 it is estimated that almost one in two people (47%) will get cancer at some point in their lives.

On the other hand, the Middle East & Africa has the least share in the EMEA surgical equipment market due to presence of poor economy especially in Africa region. Majority of the market of this region is held by the Middle East due to a well-developed healthcare sector and huge healthcare expenditure.

Key Players
Smith & Nephew (Europe), B. Braun Melsungen AG (Europe), Erbe Elektromedizin GmbH (Europe), Ethicon US, LLC. (U.S.), COVIDIEN. (Europe), CONMED Corporation. (U.S.), Integra LifeSciences Corporation. (U.S.), Valeant. (Canada), KLS Martin Group (Europe), and others.


About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:
Market Research Future
Office No. 524/528,
Amanora Chambers Magarpatta Road,
Hadapsar Pune - 411028
Maharashtra, India
+1 646 845 9312